Prenatal screens revealed blood B positive, antibody negative, group B strep status unknown, hepatitis B surface antigen negative, Rubella immune, rapid plasma reagin nonreactive.
She was treated with betamethasone at that time and discharged to home on Terbutaline.
She was admitted again on the day of delivery for uterine contractions and cervical dilatation.
The mother with cesarean section for breech positioning of twin B.
This twin emerged with tone but apnea and received brief positive pressure ventilation in the Delivery Room.
He was transported to the [**Known lastname **] Intensive Care Unit with blow-by oxygen for monitoring and treatment of prematurity.
RESPIRATORY:  Shortly after admission to the [**Known lastname **] Intensive Care Unit the infant was placed on continuous positive airway pressure but continued to have increased work of breathing.
He was intubated and received one dose of Surfactant.
Maximum vent settings were a peak expiratory flow of 24, with a positive end-expiratory pressure of 5, and a rate of 20, with an FIO2 of 21% to 35%.
He was weaned to continuous positive airway pressure on day of life two and then off of continuous positive airway pressure to room air on day of life four.
He has not had any episodes of apnea of prematurity and has not required methylxanthine therapy.
No fluid boluses or pressors have been required for blood pressure support.
FLUIDS/ELECTROLYTES/NUTRITION:  Upon admission to the [**Known lastname **] Intensive Care Unit intravenous fluids of D-10-W were initiated at 80 cc/kg per day.
Enteral feeds were initiated on day of life two, and he advanced to full volume feeds of premature Enfamil at 120 cc/kg by day of life four without difficulty.
Plan is to continue advancment (15 cc/k [**Hospital1 **]) for goal TF of 150 cc/k/day.
No blood products have been given during his hospitalization.
He received a 48-hour course of ampicillin and gentamicin.
OPHTHALMOLOGY:  Ophthalmologic was not indicated.
IMMUNIZATIONS RECOMMENDED:  Synagis respiratory syncytial virus prophylaxis should be considered from [**Month (only) 359**] through [**Month (only) 547**] for infants who meet any of the following three criteria:  (1) Born at less than 32 weeks.
Influenza immunization should be considered annually in the Fall for preterm infants with chronic lung disease once they reach six months of age.
Before this age, the family and other care givers should be considered for immunization against influenza to protect the infant.
